242 related articles for article (PubMed ID: 20478744)
1. Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.
Akimova T; Ge G; Golovina T; Mikheeva T; Wang L; Riley JL; Hancock WW
Clin Immunol; 2010 Sep; 136(3):348-63. PubMed ID: 20478744
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.
de Zoeten EF; Wang L; Butler K; Beier UH; Akimova T; Sai H; Bradner JE; Mazitschek R; Kozikowski AP; Matthias P; Hancock WW
Mol Cell Biol; 2011 May; 31(10):2066-78. PubMed ID: 21444725
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors and transplantation.
Tao R; de Zoeten EF; Ozkaynak E; Wang L; Li B; Greene MI; Wells AD; Hancock WW
Curr Opin Immunol; 2007 Oct; 19(5):589-95. PubMed ID: 17719760
[TBL] [Abstract][Full Text] [Related]
4. Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation.
Wang L; Beier UH; Akimova T; Dahiya S; Han R; Samanta A; Levine MH; Hancock WW
Am J Transplant; 2018 Jul; 18(7):1596-1603. PubMed ID: 29603600
[TBL] [Abstract][Full Text] [Related]
5. Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function.
Huang J; Wang L; Dahiya S; Beier UH; Han R; Samanta A; Bergman J; Sotomayor EM; Seto E; Kozikowski AP; Hancock WW
Sci Rep; 2017 Aug; 7(1):8626. PubMed ID: 28819166
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms.
Beier UH; Wang L; Han R; Akimova T; Liu Y; Hancock WW
Sci Signal; 2012 Jun; 5(229):ra45. PubMed ID: 22715468
[TBL] [Abstract][Full Text] [Related]
8. Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.
Shen L; Ciesielski M; Ramakrishnan S; Miles KM; Ellis L; Sotomayor P; Shrikant P; Fenstermaker R; Pili R
PLoS One; 2012; 7(1):e30815. PubMed ID: 22303460
[TBL] [Abstract][Full Text] [Related]
9. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance.
Wang L; Tao R; Hancock WW
Immunol Cell Biol; 2009; 87(3):195-202. PubMed ID: 19172156
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin A promotes the generation and suppressive functions of regulatory T cells.
Doñas C; Fritz M; Manríquez V; Tejón G; Bono MR; Loyola A; Rosemblatt M
Clin Dev Immunol; 2013; 2013():679804. PubMed ID: 23737814
[TBL] [Abstract][Full Text] [Related]
11. Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells.
von Knethen A; Heinicke U; Weigert A; Zacharowski K; Brüne B
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235291
[TBL] [Abstract][Full Text] [Related]
12. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors.
Sugimoto K; Itoh T; Takita M; Shimoda M; Chujo D; SoRelle JA; Naziruddin B; Levy MF; Shimada M; Matsumoto S
Transpl Int; 2014 Apr; 27(4):408-15. PubMed ID: 24410777
[TBL] [Abstract][Full Text] [Related]
13. Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.
Beier UH; Akimova T; Liu Y; Wang L; Hancock WW
Curr Opin Immunol; 2011 Oct; 23(5):670-8. PubMed ID: 21798734
[TBL] [Abstract][Full Text] [Related]
14. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
Wang L; Liu Y; Han R; Beier UH; Bhatti TR; Akimova T; Greene MI; Hiebert SW; Hancock WW
J Clin Invest; 2015 Mar; 125(3):1111-23. PubMed ID: 25642770
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.
de Zoeten EF; Wang L; Sai H; Dillmann WH; Hancock WW
Gastroenterology; 2010 Feb; 138(2):583-94. PubMed ID: 19879272
[TBL] [Abstract][Full Text] [Related]
17. Deacetylase inhibition promotes the generation and function of regulatory T cells.
Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
[TBL] [Abstract][Full Text] [Related]
18. Rationale for HDAC inhibitor therapy in autoimmunity and transplantation.
Hancock WW
Handb Exp Pharmacol; 2011; 206():103-23. PubMed ID: 21879448
[TBL] [Abstract][Full Text] [Related]
19. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
[TBL] [Abstract][Full Text] [Related]
20. Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.
Saouaf SJ; Li B; Zhang G; Shen Y; Furuuchi N; Hancock WW; Greene MI
Exp Mol Pathol; 2009 Oct; 87(2):99-104. PubMed ID: 19577564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
